Status:
UNKNOWN
Efficacy and Safety of Colistin Based Antibiotic Therapy
Lead Sponsor:
Ain Shams University
Conditions:
Septicemia
Bacterial Infections
Eligibility:
All Genders
Phase:
PHASE1
PHASE2
Brief Summary
To evaluate the efficacy and safety of antibiotic combinations containing Colistin in the treatment of children with multidrug-resistant gram negative infections admitted in the pediatric surgery inte...
Detailed Description
Patients and Methods Design of the study: \- Prospective, Randomized, interventional study. Setting: \- The study will be conducted in the pediatric surgery intensive care unit in Children's Hospi...
Eligibility Criteria
Inclusion
- All children with culture proven nosocomial infections due to multidrug resistance gram-negative organisms
Exclusion
- 1\. Patients who started on Colistin treatment outside the pediatric surgery intensive care unit and transferred to the unit afterward will be excluded.
- 2\. Patients who will receive \<6 doses of intravenous Colistin will be excluded.
- 3\. Patients received Imipenem or Colistin-Imipenem compination as empirical antibiotic.
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04764058
Start Date
September 1 2017
End Date
September 1 2021
Last Update
February 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams Univesity Hospital
Cairo, Egypt